Nanotechnology-based delivery systems for antimicrobial peptides

dc.contributor.authorAdewale, Oluwaseun Fadaka
dc.contributor.authorSibuyi, Nicole Remaliah Samantha
dc.contributor.authorMadiehe, Abram Madimabe
dc.contributor.authorMeyer, Mervin
dc.date.accessioned2022-08-15T10:09:02Z
dc.date.available2022-08-15T10:09:02Z
dc.date.issued2021
dc.description.abstractAntimicrobial resistance (AMR) is a significant threat to global health. The conventional antibiotic pool has been depleted, forcing the investigation of novel and alternative antimicrobial strategies. Antimicrobial peptides (AMPs) have shown potential as alternative diagnostic and therapeutic agents in biomedical applications. To date, over 3000 AMPs have been identified, but only a fraction of these have been approved for clinical trials. Their clinical applications are limited to topical application due to their systemic toxicity, susceptibility to protease degradation, short half-life, and rapid renal clearance. To circumvent these challenges and improve AMP’s efficacy, different approaches such as peptide chemical modifications and the development of AMP delivery systems have been employed. Nanomaterials have been shown to improve the activity of antimicrobial drugs by providing support and synergistic effect against pathogenic microbes. This paper describes the role of nanotechnology in the targeted delivery of AMPs, and some of the nano-based delivery strategies for AMPs are discussed with a clear focus on metallic nanoparticle (MNP) formulations.en_US
dc.identifier.citationFadaka, A. O., Sibuyi, N. R. S., Madiehe, A. M., & Meyer, M. (2021). Nanotechnology-based delivery systems for antimicrobial peptides. Pharmaceutics, 13(11) doi:10.3390/pharmaceutics13111795en_US
dc.identifier.issn19994923
dc.identifier.urihttps://doi.org/10.3390/pharmaceutics13111795
dc.identifier.urihttp://hdl.handle.net/10566/7732
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.subjectAntimicrobial peptidesen_US
dc.subjectAntimicrobial resistanceen_US
dc.subjectDrug delivery systemsen_US
dc.subjectNanocarriersen_US
dc.subjectDrug resistanceen_US
dc.titleNanotechnology-based delivery systems for antimicrobial peptidesen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
fadaka_nsc_2021.pdf
Size:
1.98 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: